## CHKP: Check Point Software Technologies Ltd. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 2.30 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($179.92)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Citigroup | $210 | $200 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Citigroup | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 27.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Blackrock Inc.: 5.8% (+0.7%)
- Massachusetts Financ: 5.6% (+27.1%)
- Ninety One UK Ltd: 4.7% (+100.7%)
- Boston Partners: 2.3% (-12.7%)
- First Trust Advisors: 2.3% (+31.4%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 8.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.30 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%, margin 38%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.3B |
| Beta | 0.61 |
| 52W Range | $178.64 - $234.36 |
| Short Interest | 5.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.30 |
| Forward P/E | 17.9 |
| Current P/E | 16.8 |
| YoY Growth | -6.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 0.9% to -1.4% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 47. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.40% (CS: 38) | Neutral |
| RSI_14 | 47.2 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 0.983x | Below |
| vs SMA200 | 0.916x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $189.44
- **Stop Loss:** $179.92 (5.0% risk)
- **Target:** $198.96 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 126
- **Position Value:** $23,869.44
- **Portfolio %:** 23.87%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $2.77)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.45 | $3.94 | +60.7% |
| 2025Q2 | $2.36 | $2.37 | +0.3% |
| 2025Q1 | $2.19 | $2.21 | +1.1% |
| 2024Q4 | $2.65 | $2.70 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*